Literature DB >> 28115295

Heterochromatin remodeling in embryonic stem cells proceeds through stochastic de-stabilization of regional steady-states.

Anastasia Christogianni1, Eleftheria Chatzantonaki2, Katerina Soupsana3, Ioannis Giannios2, Aggeliki Platania2, Anastasia S Politou3, Spyros Georgatos4.   

Abstract

Cell differentiation is associated with progressive immobilization of chromatin proteins, expansion of heterochromatin, decrease of global transcriptional activity and induction of lineage-specific genes. However, how these processes relate to one another remains unknown. We show here that the heterochromatic domains of mouse embryonic stem cells (ESCs) are dynamically distinct and possesses a mosaic sub-structure. Although random spatio-temporal fluctuations reshuffle continuously the chromatin landscape, each heterochromatic territory maintains its dynamic profile, exhibiting robustness and resembling a quasi-steady state. Transitions towards less dynamic states are detected sporadically as ESCs downregulate Nanog and exit the self-renewal phase. These transitions increase in frequency after lineage-commitment, but evolve differently depending on cellular context and transcriptional status. We propose that chromatin remodeling is a step-wise process, which involves stochastic de-stabilization of regional steady states and formation of new dynamic ensembles in coordination to changes in the gene expression program.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Chromatin remodeling; Frap; Heterochromatin; Heterochromatin protein 1; Protein dynamics; Stem cells

Mesh:

Substances:

Year:  2017        PMID: 28115295     DOI: 10.1016/j.bbagrm.2017.01.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  1 in total

1.  Rapid induction of pancreatic cancer cells to cancer stem cells via heterochromatin modulation.

Authors:  Zhengyan Xu; Yanjun Jia; Xiaoxi Huang; Nianhua Feng; Ying Li
Journal:  Cell Cycle       Date:  2018-07-25       Impact factor: 4.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.